{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:13:54Z","timestamp":1788574434177,"version":"build-2803163510"},"reference-count":40,"publisher":"Journal of the ASEAN Federation of Endocrine Societies (JAFES)","issue":"2","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J ASEAN Fed Endocr Soc"],"abstract":"<jats:p>Background. Diabetes Mellitus Type 2 (T2DM) is a significant health concern for Hajj pilgrims, with glycaemic control crucial for their well-being during the pilgrimage. Physical health is key to determining istithaah, including HbA1c and fasting blood glucose tests for prospective Hajj pilgrims with type 2 diabetes mellitus.\nObjective. This study describes HbA1c and fasting blood glucose levels as indicators of glycaemic control among Indonesian prospective Hajj pilgrims diagnosed with T2DM based on laboratory results from medical check-ups for the 2024 departure in Tangerang City, and assesses their association with demographic factors.\nMethodology. A cross-sectional study analyzed HbA1c from 125 pre-departure medical check-ups of 75 female and 50 male prospective Hajj pilgrims. Data were collected from medical records at a public hospital in Tangerang City and from the Hajj Integrated Computer Health System (SISKOHATKES) application in 2024. Statistical analysis was performed using the Chi-square test or Fisher's exact test, as appropriate.\nResult. This study showed that most subjects were female, with the most common age group being 18\u201359 years (adult). The most prevalent health eligibility (istitaah) status was eligible with assistance. More than 50% of Hajj pilgrims with T2DM had comorbid conditions such as hypertension, cardiomegaly, and hyperlipidaemia. The mean HbA1c level was 9.82 \u00b1 2.2%, with most participants exhibiting uncontrolled glycaemic status (HbA1c &gt;7.5%). Similarly, the mean fasting blood glucose level was 197.0 \u00b1 67.8 mg\/dL, with the majority also falling within the uncontrolled range (fasting blood glucose &gt;126 mg\/dL). There was no significant correlation between HbA1c levels and age or sex.\nThis study showed that most subjects were female, with the most common age group being 18\u201359 years (adult). The most prevalent health eligibility (istitaah) status was eligible with assistance. More than 50% of Hajj pilgrims with T2DM had comorbid conditions such as hypertension, cardiomegaly, and hyperlipidaemia. The mean HbA1c level was 9.82 \u00b1 2.2%, with most participants exhibiting uncontrolled glycaemic status (HbA1c &gt;7.5%). Similarly, the mean fasting blood glucose level was 197.0 \u00b1 67.8 mg\/dL, with the majority also falling within the uncontrolled range (fasting blood glucose &gt;126 mg\/dL). There was no significant correlation between HbA1c levels and age or sex.\nConclusion. The majority of prospective Hajj pilgrims with T2DM are uncontrolled in terms of glycaemic status. These findings require comprehensive assessment and management strategies before, during, and after the Hajj pilgrimage to minimize risk and prevent complications.<\/jats:p>","DOI":"10.15605\/jafes.041.02.6347","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:49:18Z","timestamp":1788572958000},"page":"85-91","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Glycemic Control Among Prospective Hajj Pilgrims With Type 2 Diabetes Mellitus in Tangerang City, Indonesia"],"prefix":"10.15605","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3810-2268","authenticated-orcid":false,"given":"Muniroh","family":"Muniroh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustika Putri","family":"Hanifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwi","family":"Tyastuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5787-7044","authenticated-orcid":false,"given":"Yusran Tamsyi","family":"Sopian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Sumantri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6244","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"87668","doi-asserted-by":"crossref","unstructured":"1. Showail AJ. Solving Hajj and Umrah : A survey. IEEE Access. 2022;10:75404\u201327. https:\/\/doi.org\/10.1109\/ACCESS.2022.3190853","DOI":"10.1109\/ACCESS.2022.3190853"},{"key":"87669","unstructured":"2. Kementerian Agama Republik Indonesia. Tuntunan Manasik Haji dan Umrah. Jakarta: Direktorat Jenderal Penyelenggaraan Haji dan Umrah; 2020."},{"key":"87670","unstructured":"3. Siavash M, Haghighi S. Recommendations for patients with diabetes mellitus during hajj pilgrimage. J Res Med Sci. 2012;17(10):988\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/23826004 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3698663"},{"key":"87671","doi-asserted-by":"crossref","unstructured":"4. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010;33(Suppl_1):S62\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/20042775 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2797383 https:\/\/doi.org\/10.2337\/dc10-S062.","DOI":"10.2337\/dc10-S062"},{"key":"87672","unstructured":"5. RISKESDAS. Survei Kesehatan Indonesia (SKI) 2023. Jakarta: Badan Kebijakan Pembangunan Kesehatan Kementerian Kesehatan Indonesia; 2023. https:\/\/layanandata.kemkes.go.id\/katalog-data\/ski\/ketersediaan-data\/ski-2023"},{"key":"87673","unstructured":"6. Safrizal S, Asriwati Amirah. Implementation of Surveillance System based on characteristics and health status of Hajj Pilgrims candidates of Banda Aceh (BTJ) in 2019. Int J Health Sci Nurs. 2019;2(9). https:\/\/www.ijojournals.com\/index.php\/hsn\/article\/view\/216\/69"},{"key":"87674","doi-asserted-by":"crossref","unstructured":"7. Beshyah S, Sherif I. Care for people with diabetes during the Moslem pilgrimage (Haj): An overview. Libyan J Med. 2008;3(1):39\u201341. https:\/\/pubmed.ncbi.nlm.nih.gov\/21499480 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3074328 https:\/\/doi.org\/10.4176\/071211","DOI":"10.4176\/071211"},{"key":"87675","doi-asserted-by":"crossref","unstructured":"8. Al-Ghamdi SM, Akbar HO, Qari YA, Fathaldin OA, Al-Rashed RS. Pattern of admission to hospitals during Muslim pilgrimage (Hajj). Saudi Med J. 2003;24(10):1073\u20136. https:\/\/pubmed.ncbi.nlm.nih.gov\/14578971","DOI":"10.15537\/1658-3175.2185"},{"key":"87676","doi-asserted-by":"crossref","unstructured":"9. Maan HB, Meo SA, Al Rouq F, Meo IMU, Gacuan ME, Alkhalifah JM. Effect of glycated hemoglobin (HbA1c) and duration of disease on lung functions in type 2 diabetic patients. Int J Environ Res Public Health. 2021;18(13):6970. https:\/\/pubmed.ncbi.nlm.nih.gov\/34209922 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8297156 https:\/\/doi.org\/10.3390\/ijerph18136970","DOI":"10.3390\/ijerph18136970"},{"key":"87677","unstructured":"10. Kementerian Kesehatan Indonesia. Petunjuk Teknis Pemeriksaan dan Pembinaan Kesehatan Haji (Petunjuk Teknis Permenkes Nomor 15 Tahun 2016). Jakarta, Indonesia; 2016."},{"key":"87678","doi-asserted-by":"crossref","unstructured":"11. Kurniawan LB. HbA1c as diabetes mellitus biomarker and its methods evolution. Indones J Clin Pathol Med Lab. 2024;30(2):191\u20136. https:\/\/doi.org\/10.24293\/ijcpml.v30i2.2191","DOI":"10.24293\/ijcpml.v30i2.2191"},{"key":"87679","doi-asserted-by":"crossref","unstructured":"12. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016 Jan;11:BMI.S38440. https:\/\/pubmed.ncbi.nlm.nih.gov\/27398023 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4933534 https:\/\/doi.org\/10.4137\/BMI.S38440","DOI":"10.4137\/BMI.S38440"},{"key":"87680","doi-asserted-by":"crossref","unstructured":"13. Sari TM, Muhajarah K. Karakteristik Jemaah Haji dan Peran Dinas Kesehatan Kota Semarang dalam Penguatan Istitaah Kesehatan. J Manaj Pendidik DAN ILMU Sos. 2024;5(3):224\u201332. https:\/\/doi.org\/10.38035\/jmpis.v5i3","DOI":"10.38035\/jmpis.v5i3.1917"},{"key":"87681","doi-asserted-by":"crossref","unstructured":"14. Yousuf S, Ahmedani MY. Features and frequency of complications among pilgrims with diabetes during Hajj. J Diabetol. 2024;15(2):217\u201321. https:\/\/doi.org\/10.4103\/jod.jod_111_23","DOI":"10.4103\/jod.jod_111_23"},{"key":"87682","doi-asserted-by":"crossref","unstructured":"15. Ibrahim M, Abdelaziz SI, Abu Almagd M, et al. Recommendations for management of diabetes and its complications during Hajj (Muslim pilgrimage). BMJ Open Diabetes Res Care. 2018;6(1):e000574. https:\/\/pubmed.ncbi.nlm.nih.gov\/38569944 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6104783 https:\/\/doi.org\/10.1136\/bmjdrc-2018-000574","DOI":"10.1136\/bmjdrc-2018-000574"},{"key":"87683","unstructured":"16. Directorate General of Hajj and Umrah M of RA of the R of Indonesia. Hajj and Umrah Ritual Guide. Jakarta, Indonesia; 2023. http:\/\/haji.kemenag.go.id"},{"key":"87684","doi-asserted-by":"crossref","unstructured":"17. Khogeer Z, Alnifaee R, Alyamani S, et al. Acute complications of diabetes among pilgrims during Hajj 2017: A brief report. Diabetes Ther. 2020;11(3):747\u201351. https:\/\/pubmed.ncbi.nlm.nih.gov\/32036541 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7048894 https:\/\/doi.org\/10.1007\/s13300-020-00774-5","DOI":"10.1007\/s13300-020-00774-5"},{"key":"87685","doi-asserted-by":"crossref","unstructured":"18. Farmaki P, Damaskos C, Garmpis N, Garmpi A, Savvanis S, Diamantis E. Complications of type 2 diabetes mellitus. Curr Cardiol Rev. 2021;16(4):249\u201351. https:\/\/pubmed.ncbi.nlm.nih.gov\/33407062 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7903505 https:\/\/doi.org\/10.2174\/1573403X1604201229115531","DOI":"10.2174\/1573403X1604201229115531"},{"key":"87686","doi-asserted-by":"crossref","unstructured":"19. Kane JP, Pullinger CR, Goldfine ID, Malloy MJ. Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus. Curr Opin Pharmacol. 2021;61:21\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/34562838 https:\/\/doi.org\/10.1016\/j.coph.2021.08.013","DOI":"10.1016\/j.coph.2021.08.013"},{"key":"87687","doi-asserted-by":"crossref","unstructured":"20. Hirano T. Pathophysiology of diabetic dyslipidemia. J Atheroscler Thromb. 2018;25(9):771\u201382. https:\/\/pubmed.ncbi.nlm.nih.gov\/29998913 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6143775 https:\/\/doi.org\/10.5551\/jat.RV17023","DOI":"10.5551\/jat.RV17023"},{"key":"87688","doi-asserted-by":"crossref","unstructured":"21. Naseri MW, Esmat HA, Bahee MD. Prevalence of hypertension in type-2 diabetes mellitus. Ann Med Surg. 2022;78:1-4. https:\/\/pubmed.ncbi.nlm.nih.gov\/35620043 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9127167 https:\/\/doi.org\/10.1016\/j.amsu.2022.103758","DOI":"10.1016\/j.amsu.2022.103758"},{"key":"87689","doi-asserted-by":"crossref","unstructured":"22. Yezli S, Mushi A, Almuzaini Y, Balkhi B, Yassin Y, Khan A. Prevalence of diabetes and hypertension among Hajj pilgrims: A systematic review. Int J Environ Res Public Health. 2021;18(3):1155. https:\/\/pubmed.ncbi.nlm.nih.gov\/33525524 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7908531 https:\/\/doi.org\/10.3390\/ijerph18031155","DOI":"10.3390\/ijerph18031155"},{"key":"87690","doi-asserted-by":"crossref","unstructured":"23. Lackland DT, Weber MA. Global burden of cardiovascular disease and stroke: Hypertension at the core. Can J Cardiol. 2015;31(5):569\u201371. https:\/\/pubmed.ncbi.nlm.nih.gov\/25795106 https:\/\/doi.org\/10.1016\/j.cjca.2015.01.009","DOI":"10.1016\/j.cjca.2015.01.009"},{"key":"87691","doi-asserted-by":"crossref","unstructured":"24. Madani TA, Ghabrah TM, Albarrak AM, et al. Causes of admission to intensive care units in the Hajj period of the Islamic Year 1424 (2004). Ann Saudi Med. 2007;27(2):101\u20135. https:\/\/pubmed.ncbi.nlm.nih.gov\/17356316 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6077038 https:\/\/doi.org\/10.5144\/0256-4947.2007.101","DOI":"10.5144\/0256-4947.2007.101"},{"key":"87692","doi-asserted-by":"crossref","unstructured":"25. Arabi YM, Alhamid SM. Emergency room to the intensive care unit in Hajj. The chain of life. Saudi Med J. 2006;27(7):937\u201341. https:\/\/pubmed.ncbi.nlm.nih.gov\/16830008","DOI":"10.15537\/1658-3175.3491"},{"key":"87693","doi-asserted-by":"crossref","unstructured":"26. Khan ID, Khan SA, Asima B, Hussaini SB, Zakiuddin M, Faisal FA. Morbidity and mortality amongst Indian Hajj pilgrims: A 3-year experience of Indian Hajj medical mission in mass-gathering medicine. J Infect Public Health. 2018;11(2):165\u201370. https:\/\/pubmed.ncbi.nlm.nih.gov\/28668659 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7102688 https:\/\/doi.org\/10.1016\/j.jiph.2017.06.004","DOI":"10.1016\/j.jiph.2017.06.004"},{"key":"87694","doi-asserted-by":"crossref","unstructured":"27. Pane M, Kong FYM, Purnama TB, et al. Indonesian Hajj cohorts and mortality in Saudi Arabia from 2004 to 2011. J Epidemiol Glob Health. 2019;9(1):11-8. https:\/\/pubmed.ncbi.nlm.nih.gov\/30932384 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7310759 https:\/\/doi.org\/10.2991\/jegh.k.181231.001","DOI":"10.2991\/jegh.k.181231.001"},{"key":"87695","doi-asserted-by":"crossref","unstructured":"28. Al Shimemeri A. Cardiovascular disease in Hajj pilgrims. J Saudi Heart Assoc. 2012;24(2):123\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/23960680 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3727516 https:\/\/doi.org\/10.1016\/j.jsha.2012.02.004","DOI":"10.1016\/j.jsha.2012.02.004"},{"key":"87696","doi-asserted-by":"crossref","unstructured":"29. Jia G, Sowers JR. Hypertension in diabetes: An update of basic mechanisms and clinical disease. Hypertension. 2021;78(5):1197\u2013205. https:\/\/pubmed.ncbi.nlm.nih.gov\/34601960 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8516748 https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.17981","DOI":"10.1161\/HYPERTENSIONAHA.121.17981"},{"key":"87697","doi-asserted-by":"crossref","unstructured":"30. Leow M. Glycated Hemoglobin (HbA1c): Clinical applications of a mathematical concept. Acta Inform Medica. 2016;24(4):233-8. https:\/\/pubmed.ncbi.nlm.nih.gov\/27708483 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5037982 https:\/\/doi.org\/10.5455\/aim.2016.24.233-238","DOI":"10.5455\/aim.2016.24.233-238"},{"key":"87698","doi-asserted-by":"crossref","unstructured":"31. Kaiafa G, Veneti S, Polychronopoulos G, et al. Is HbA1c an ideal biomarker of well-controlled diabetes? Postgrad Med J. 2021;97(1148):380\u20133. https:\/\/pubmed.ncbi.nlm.nih.gov\/32913038 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10016911 https:\/\/doi.org\/10.1136\/postgradmedj-2020-138756","DOI":"10.1136\/postgradmedj-2020-138756"},{"key":"87699","doi-asserted-by":"crossref","unstructured":"32. Suastika K. Clinical use and limitation of hemoglobin A1c examination. Clin Diabetol. 2021;10(3):299-306. https:\/\/doi.org\/10.5603\/DK.a2021.0045","DOI":"10.5603\/DK.a2021.0045"},{"key":"87700","doi-asserted-by":"crossref","unstructured":"33. Anggraini R, Nadatein I, Astuti P. Relationship of HbA1c with fasting blood glucose on diagnostic values and lifestyle in type ii diabetes mellitus patients. Medicra J Med Lab Sci. 2020;3(1):5\u201311. https:\/\/doi.org\/10.21070\/medicra.v3i1.651","DOI":"10.21070\/medicra.v3i1.651"},{"key":"87701","doi-asserted-by":"crossref","unstructured":"34. Stedman M, Heald AH, Holland D, Halsall I, Green L, Wu P, et al. The impact of age and sex on fasting plasma glucose and glycated haemoglobin (HbA1c) in the non-diabetes population. Diabetes Ther. 2025;16(2):257-67. https:\/\/pubmed.ncbi.nlm.nih.gov\/39704964 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC11794718 https:\/\/doi.org\/10.1007\/s13300-024-01680-w","DOI":"10.1007\/s13300-024-01680-w"},{"key":"87702","unstructured":"35. Soelistijo S.A., Lindarto D., Decroli E., et al. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia. PB-PERKENI; 2021."},{"key":"87703","doi-asserted-by":"crossref","unstructured":"36. Roth J, M\u00fcller N, Lehmann T, Heinemann L, Wolf G, M\u00fcller UA. HbA1c and age in non-diabetic subjects: An ignored association? Exp Clin Endocrinol Diabetes. 2016;124(10):637\u201342. https:\/\/pubmed.ncbi.nlm.nih.gov\/27219885 https:\/\/doi.org\/10.1055\/s-0042-105440","DOI":"10.1055\/s-0042-105440"},{"key":"87704","doi-asserted-by":"crossref","unstructured":"37. Shaikh S, Ashraf H, Shaikh K, et al. Diabetes care during Hajj. Diabetes Ther. 2020;11(12):2829\u201344. https:\/\/pubmed.ncbi.nlm.nih.gov\/33063269 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7561249 https:\/\/doi.org\/10.1007\/s13300-020-00944-5","DOI":"10.1007\/s13300-020-00944-5"},{"key":"87705","doi-asserted-by":"crossref","unstructured":"38. Khan SA, Bhat AR, Khan LA. Hypoglycemia in diabetics during Hajj. Saudi Med J. 2002;23(12):1548. https:\/\/pubmed.ncbi.nlm.nih.gov\/12518212","DOI":"10.15537\/1658-3175.1863"},{"key":"87706","doi-asserted-by":"crossref","unstructured":"39. G\u00fclsen \u015e, Deniz KE, Ba\u015fak C, Alper G, Ye\u015fil BS, Bet\u00fcl E. The effect of age and gender on HbA1c levels in adults without diabetes mellitus. J Med Biochem. 2023;42(4):714-21. https:\/\/pubmed.ncbi.nlm.nih.gov\/38084249 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10710816 https:\/\/doi.org\/10.5937\/jomb0-44190","DOI":"10.5937\/jomb0-44190"},{"key":"87707","doi-asserted-by":"crossref","unstructured":"40. Adriani D, Hurin S, Amani P. Hubungan Indeks Massa Tubuh dengan Kadar HbA1C pada Penderita Diabetes Melitus Tipe 2. J Penelit Dan Karya Ilm Lemb Penelit Univ Trisakti. 2023;8(2):190\u20138. https:\/\/doi.org\/10.25105\/pdk.v8i2.14034","DOI":"10.25105\/pdk.v8i2.14034"}],"container-title":["Journal of the ASEAN Federation of Endocrine Societies"],"original-title":[],"link":[{"URL":"https:\/\/asean-endocrinejournal.org\/index.php\/JAFES\/article\/download\/6347\/5359","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/asean-endocrinejournal.org\/index.php\/JAFES\/article\/download\/6347\/5359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:49:22Z","timestamp":1788572962000},"score":1,"resource":{"primary":{"URL":"https:\/\/asean-endocrinejournal.org\/index.php\/JAFES\/article\/view\/6347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,8,31]]}},"URL":"https:\/\/doi.org\/10.15605\/jafes.041.02.6347","relation":{},"ISSN":["2308-118X","0857-1074"],"issn-type":[{"value":"2308-118X","type":"electronic"},{"value":"0857-1074","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}